Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is a novel approach for canine cancer therapy. Here we describe, for the first time, the characterization and the use of VACV strain GLV-5b451 expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb...

詳細記述

書誌詳細

主要な著者:	Marion Adelfinger, Simon Bessler, Alexa Frentzen, Alexander Cecil, Johanna Langbein-Laugwitz, Ivaylo Gentschev, Aladar A. Szalay
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2015-07-01
シリーズ:	Viruses
主題:	oncolytic virus cancer canine cancer cell lines antibody production angiogenesis canine soft tissue sarcoma (CSTS) canine cancer therapy
オンライン･アクセス:	http://www.mdpi.com/1999-4915/7/7/2811
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!